<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:16:31Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14763" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14763</identifier><datestamp>2026-10-18T21:14:25Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Synthesis and anti-proliferative activity of fluoro-substituted chalcones</dc:title><dc:creator>Burmaoglu, Serdar</dc:creator><dc:creator>Algul, Oztekin</dc:creator><dc:creator>Anil, Derya Aktas</dc:creator><dc:creator>Gobek, Arzu</dc:creator><dc:creator>Duran, Gulay Gulbol</dc:creator><dc:creator>Ersan, Ronak Haj</dc:creator><dc:creator>Duran, Nizami</dc:creator><dc:subject>Anti-proliferative activity</dc:subject><dc:subject>Chalcone</dc:subject><dc:subject>Claisen-Schmidt condensation</dc:subject><dc:subject>Organofluorine</dc:subject><dc:subject>Synthesis</dc:subject><dc:subject>Antineoplastic Agents</dc:subject><dc:subject>Cell Line, Tumor</dc:subject><dc:subject>Cell Proliferation</dc:subject><dc:subject>Cell Survival</dc:subject><dc:subject>Dose-Response Relationship, Drug</dc:subject><dc:subject>Drug Screening Assays, Antitumor</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Molecular Structure</dc:subject><dc:subject>Structure-Activity Relationship</dc:subject><dc:subject>antineoplastic agent</dc:subject><dc:subject>chalcone derivative</dc:subject><dc:subject>fluorine derivative</dc:subject><dc:subject>methotrexate</dc:subject><dc:subject>A375 cell line</dc:subject><dc:subject>A498 cell line</dc:subject><dc:subject>A549 cell line</dc:subject><dc:subject>analytic method</dc:subject><dc:subject>antiproliferative activity</dc:subject><dc:subject>Article</dc:subject><dc:subject>cancer cell line</dc:subject><dc:subject>carbon nuclear magnetic resonance</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>drug synthesis</dc:subject><dc:subject>elemental analysis</dc:subject><dc:subject>female</dc:subject><dc:description>A series of novel fluoro-substituted chalcone derivatives have been synthesized. All synthesized compounds were characterized by 1H nuclear magnetic resonance (NMR), 13C NMR, and elemental analysis. Their anti-proliferative activities were evaluated against five cancer cells lines, namely, A549, A498, HeLa, A375, and HepG2 using the MTT method. Most of the compounds showed moderate to high activity with IC50 values in the range of 0.029-0.729 μM. Of all the synthesized compounds, 10 and 19 exhibited the most potent anti-proliferative activities against cancer cells, and 10 was identified as the most promising compound. © 2016 Elsevier Ltd. All rights reserved.</dc:description><dc:publisher>Elsevier Ltd</dc:publisher><dc:date>2016</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14763</dc:identifier><dc:identifier>https://doi.org/10.1016/j.bmcl.2016.04.096</dc:identifier><dc:identifier>0960-894X</dc:identifier><dc:language>en</dc:language><dc:relation>Bioorganic and Medicinal Chemistry Letters</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14763</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>